TGFB1 and neoplasm: Indeed, a recent study suggests that tumor‐derived EVs can induce fibroblast heterogeneity in CRC models determined by the EMT status of the tumor cells through a miR‐200/ZEB1/TGF‐β dependent mechanism [155], opening a window to the possibility that other cell types, including tumor cells, could be also affected by similar mechanisms.